Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0S9SX
|
|||
Former ID |
DNC005794
|
|||
Drug Name |
4-(2-Ethyl-4-m-tolyl-thiazol-5-yl)-pyridine
|
|||
Synonyms |
CHEMBL198334; 4-(2-Ethyl-4-m-tolyl-thiazol-5-yl)-pyridine; BDBM50173628
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C17H16N2S
|
|||
Canonical SMILES |
CCC1=NC(=C(S1)C2=CC=NC=C2)C3=CC=CC(=C3)C
|
|||
InChI |
1S/C17H16N2S/c1-3-15-19-16(14-6-4-5-12(2)11-14)17(20-15)13-7-9-18-10-8-13/h4-11H,3H2,1-2H3
|
|||
InChIKey |
QUKIIQWKXMTFAE-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (T... J Med Chem. 2005 Sep 22;48(19):5966-79. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.